Biopolym. Cell. 2015; 31(4):279-284.
Molecular and Cell Biotechnologies
Development of the chromatographic medium for the affinity isolation of the recombinant hIFN-β1b based on immobilized single-chain antibodies
- Institute of Molecular Biology and Genetics, NAS of Ukraine
150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680 - State Institute of Genetic and Regenerative Medicine, NAMS of Ukraine
67, Vyshhorodska Str., Kyiv, Ukraine, 04114
Abstract
Aim. The development of a laboratory method for the production of immunoaffinity chromatography medium for the purification of the recombinant human IFN-β1b. Methods. A gene of the chimeric protein ScFvbINF-CBD was constructed using the DNA sequences encoding ScFv specific to hIFN-β1b and the cellulose-binding domain (CBD) of Clostridium thermocellum. The developed chimeric protein was expressed in Escherichia coli cells. The target protein was obtained in soluble, functionally active form by its renaturation from the bacterial inclusion bodies in vitro. The ScFvbINF-CBD was immobilized on a chitin carrier. Results. The introduction of CBD by gene engineering techniques enabled the oriented non-covalent immobilization of ScFvbINF-CBD on chromatographic matrix. The developed immunoaffinity medium allowed isolating the rhIFN-β1b from the complex mixture, after its renaturation from the inclusion bodies, with more than 89 % purity. Conclusion. The designed immunoaffinity medium provides isolating the rhIFN-β1b from the complex protein mixtures.
Keywords: Interferon-β1b, single-chain antibodies, immunoaffinity purification, cellulose-binding domain.
Full text: (PDF, in English)
References
[1]
Blank K, Lindner P, Diefenbach B, Plückthun A. Self-imÂmobilizing recombinant antibody fragments for immunoaffinity chromatography: generic, parallel, and scalable protein purification. Protein Expr Purif. 2002;24(2):313–22.
[2]
Berry MJ, Davies J, Smith CG, Smith I. Immobilization of Fv antibody fragments on porous silica and their utility in affinity chromatography. J Chromatogr. 1991;587(2):161-9.
[4]
Minagar A. Current and future therapies for multiple sclerosis. Scientifica (Cairo). 2013;2013:249101.
[5]
Pavlova MV, Nikolaev IuS, Irodov DM, Okunev OV, Kordium VA, Gil'chuk PV. [Characterization of a panel of mouse single-chain antibodies against recombinant human interferon beta1b]. Tsitol Genet. 2008;42(4):3-11.
[6]
Gilchuk PV, Okunev OV, Irodov DM, Pavlova MV, Yakovenko OYa. Immobilized single chain antibodies for affinity purification of recombinant human IFN-α2b. Biopolym Cell. 2006; 22(2):157–61.
[7]
Studier FW. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif. 2005;41(1):207-34.
[8]
The Protein Protocols Handbook. Ed. Walker JM. Humana Press Inc. 2009 1984 p.
[9]
Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual. New York: Cold Spring Harbor Lab. press, 1989.
[10]
Morag E, Lapidot A, Govorko D, Lamed R, Wilchek M, Bayer EA, Shoham Y. Expression, purification, and characterization of the cellulose-binding domain of the scaffoldin subunit from the cellulosome of Clostridium thermocellum. Appl Environ Microbiol. 1995;61(5):1980-6.
[11]
Bayer EA, Morag E, Lamed R. The cellulosome--a treasure-trove for biotechnology. Trends Biotechnol. 1994;12(9):379-86.
[12]
Lehtiö J, Sugiyama J, Gustavsson M, Fransson L, Linder M, Teeri TT. The binding specificity and affinity determinants of family 1 and family 3 cellulose binding modules. Proc Natl Acad Sci U S A. 2003;100(2):484-9.
[13]
Guo JQ, You SY, Li L, Zhang YZ, Huang JN, Zhang CY. Construction and high-level expression of a single-chain Fv antibody fragment specific for acidic isoferritin in EscheÂrichia coli. J Biotechnol. 2003;102(2):177–89.
[14]
Tormo J, Lamed R, Chirino AJ, Morag E, Bayer EA, Shoham Y, Steitz TA. Crystal structure of a bacterial family-III cellulose-binding domain: a general mechanism for attachment to cellulose. EMBO J. 1996;15(21):5739-51.